Health
Scientists Identify Potential Drug Candidate Against Covid-19, Stops Virus from Replicating in Host Cells – News18
Ebselen, a chemical compound with anti-viral, anti-inflammatory, anti-oxidative, bactericidal and cell-protective properties, is used to treat bipolar disorder and loss of hearing.
Using state-of-the-art computer simulations, scientists have identified a preexisting drug, used to treat multiple diseases, including bipolar disorders and hearing loss, that could prevent the novel coronavirus from replicating in host cells, an advance that may lead to a therapeutic solution against COVID-19. The study, published in the journal Science Advances, assessed the molecule main protease, Mpro, of the novel coronavirus which is a key enzyme that plays a central role in its life cycle…
-
Noosa News12 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Business14 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth
-
Noosa News14 hours agoAustralia’s biggest sheep drive, and the young drover history forgot
-
Business20 hours agoAre electric vehicle stocks a good investment today?